SCHEMBL19080180

SCHEMBL19080180

c1cc(-c2ccc3ccc4c(oc5ccc6ccccc6c54)c3c2)cc(-c2c3ccccc3c(-c3ccc4sc5ccccc5c4c3)c3ccccc23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 10/20 0.36
CYP1A2 P05177 9/20 0.36
ABCG2 Q9UNQ0 4/20 0.36
AHR P35869 2/20 0.36
PAX8 Q06710 2/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
CYP1B1 Q16678 9/20 0.33
NPC1 O15118 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
PRKDC P78527 2/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PDE5A O76074 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
ABCB1 P08183 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080193 0.92 CYP1A1 (0.38) CYP1A1CYP1A2ABCG2AHRPAX8
SCHEMBL19080209 0.90 CYP1A1 (0.39) CYP1A1CYP1A2ABCG2AHRPAX8
SCHEMBL19081712 0.89 TDP1 (0.35) CYP1A1CYP1A2ABCG2AHRPAX8
SCHEMBL19079937 0.87 CYP1A1 (0.44) CYP1A1CYP1A2ABCG2AHRPAX8
SCHEMBL19076936 0.87 ESR2 (0.32) CYP1A1CYP1B1TDP1RAB9AALDH1A1
SCHEMBL19081714 0.86 CYP1A1 (0.36) CYP1A1CYP1A2ABCG2CYP1B1TDP1
SCHEMBL19080003 0.86 CYP1A1 (0.44) CYP1A1CYP1A2ABCG2AHRPAX8
SCHEMBL19081908 0.86 CYP1A1 (0.38) CYP1A1CYP1A2ABCG2AHRPAX8
SCHEMBL19076598 0.86 TDP1 (0.33) TDP1RAB9AALDH1A1MAPTHPGD
SCHEMBL19081945 0.85 AHR (0.33) CYP1A1CYP1A2ABCG2AHRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1A2 621/4885ABCG2 4758/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1A2 621/4885ABCG2 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.